Joseph P Costantino Selected Research

Joseph P Costantino Research Topics

Disease

77	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2002
33	Neoplasms (Cancer) 01/2021 - 01/2003
11	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016 - 01/2003
3	Margins of Excision 12/2019 - 02/2016
3	Neutropenia 09/2015 - 01/2012
3	Uterine Neoplasms (Uterine Cancer) 12/2011 - 06/2006
3	Cataract (Cataracts) 06/2011 - 11/2005
3	Endometrial Neoplasms (Endometrial Cancer) 06/2011 - 11/2005
3	Amenorrhea 03/2011 - 01/2009
3	Hyperplasia 06/2010 - 02/2003
3	Venous Thrombosis (Deep-Vein Thrombosis) 07/2006 - 01/2003
2	Neoplasm Metastasis (Metastasis) 12/2019 - 07/2012
2	Fatigue 02/2016 - 09/2015
2	Hypertension (High Blood Pressure) 09/2015 - 01/2012
2	Hand-Foot Syndrome 09/2015 - 01/2012
2	Breast Carcinoma In Situ 05/2014 - 01/2003
2	Obesity 06/2012 - 09/2011
2	Polyps 12/2011 - 04/2005
2	Endometrial Hyperplasia 12/2011 - 04/2005
2	Ovarian Cysts (Ovarian Cyst) 12/2011 - 04/2005
2	Leiomyoma (Uterine Fibroids) 12/2011 - 04/2005
2	Hypersensitivity (Allergy) 10/2010 - 10/2007
2	Colonic Neoplasms (Colon Cancer) 04/2010 - 06/2007
2	Prostatic Neoplasms (Prostate Cancer) 04/2009 - 03/2009
2	Osteoporosis 06/2006 - 06/2002
1	Musculoskeletal Pain 02/2016
1	Thrombosis (Thrombus) 02/2016
1	Embolism (Embolus) 02/2016
1	Sudden Death 09/2015
1	Endocarditis 09/2015
1	Triple Negative Breast Neoplasms 07/2014
1	Heart Failure 11/2013
1	Osteonecrosis (Kienbock's Disease) 07/2012
1	Liver Diseases (Liver Disease) 07/2012
1	Insulin Resistance 06/2012
1	Inflammation (Inflammations) 06/2012
1	Mucositis 01/2012
1	Body Weight (Weight, Body) 01/2012
1	Left Ventricular Dysfunction 01/2012

Drug/Important Bio-Agent (IBA)

50	Tamoxifen FDA LinkGeneric 02/2018 - 06/2002
17	Estrogen ReceptorsIBA 02/2018 - 11/2005
17	Raloxifene Hydrochloride (Evista)FDA Link 01/2014 - 06/2002
11	Trastuzumab (Herceptin)FDA Link 10/2020 - 06/2008
9	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017 - 01/2009
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2017 - 01/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2018 - 06/2010
6	Docetaxel (Taxotere)FDA Link 07/2017 - 01/2009
6	Hormones (Hormone)IBA 02/2016 - 04/2008
5	human ERBB2 proteinIBA 01/2021 - 06/2010
5	B 31IBA 01/2019 - 12/2013
4	Progesterone Receptors (Progesterone Receptor)IBA 02/2018 - 04/2006
4	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2012
4	Selective Estrogen Receptor Modulators (SERM)IBA 07/2013 - 06/2010
4	P-2 (P 2)IBA 07/2013 - 06/2006
4	desintegron BIBA 11/2011 - 08/2006
3	AnthracyclinesIBA 07/2017 - 06/2010
3	Anastrozole (Arimidex)FDA LinkGeneric 02/2016 - 11/2011
3	Gemcitabine FDA Link 09/2015 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2015
2	Capecitabine (Xeloda)FDA Link 09/2015 - 01/2012
2	Estrogens (Estrogen)FDA Link 04/2012 - 04/2005
2	Dihydrotachysterol (AT 10)IBA 04/2012 - 08/2006
2	Taxoids (Taxanes)IBA 01/2012 - 06/2010
2	Coloring Agents (Dyes)IBA 10/2010 - 10/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2010 - 06/2007
2	Leucovorin (Folinic Acid)FDA Link 04/2010 - 06/2007
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2009 - 03/2009
2	Monoclonal AntibodiesIBA 10/2008 - 10/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2006 - 01/2006
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	olaparibIBA 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 09/2015
1	ErbB Receptors (EGF Receptor)IBA 08/2015
1	SmokeIBA 05/2014
1	Lapatinib (GW572016)FDA Link 11/2013
1	B 43IBA 11/2013
1	Pharmaceutical PreparationsIBA 09/2013
1	taxaneIBA 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2013
1	antineoplaston A10 (A 10)IBA 05/2013
1	Diphosphonates (Bisphosphonates)IBA 07/2012
1	Clodronic Acid (Clodronate)IBA 07/2012
1	AdipokinesIBA 06/2012
1	LeptinIBA 06/2012
1	Insulin (Novolin)FDA Link 06/2012
1	C-Reactive ProteinIBA 06/2012
1	Vitamin D FDA LinkGeneric 06/2012
1	AntimetabolitesIBA 01/2012

Therapy/Procedure

34	Therapeutics 01/2021 - 01/2003
13	Drug Therapy (Chemotherapy) 01/2019 - 08/2006
11	Segmental Mastectomy (Lumpectomy) 12/2019 - 01/2003
10	Chemoprevention 04/2012 - 01/2006
9	Adjuvant Chemotherapy 01/2021 - 06/2007
6	Neoadjuvant Therapy 01/2018 - 01/2012
6	Radiotherapy 02/2016 - 01/2003
3	Mastectomy (Mammectomy) 12/2019 - 08/2006
3	Hysterectomy 06/2011 - 01/2003
3	Lymph Node Excision (Lymph Node Dissection) 10/2010 - 08/2007
1	Combination Drug Therapy (Combination Chemotherapy) 09/2013
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2012